Summary: | Benign prostatic hyperplasia or hypertrophy (BPH) refers to the enlargement of the prostate gland in men due to an overgrowth of cells. Although it is not a life-threatening condition, BPH causes serious morbidity in the form of lower urinary tract symptoms (LUTS) in an estimated 50% of men older than 75 years. For moderate to severe cases of LUTS that are unresponsive to medical management, surgery is the primary choice of treatment, the most common form being transurethral resection of the prostate (TURP). Prostatectomy (or a complete removal of the prostate) may be considered if the urethra is completely blocked or the prostate is extremely enlarged. To limit the occurrence of side effects, several minimally-invasive treatments have been developed. This review aims to summarize evidence regarding the clinical effectiveness of select minimally-invasive techniques for the treatment of LUTS associated with BPH.
|